Overview

Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The present trial will establish a prospective sequential Allogeneic Stem Cell Transplantation (allo-SCT) treatment combining both salvage chemotherapy and Reduced Intensity Conditioning (RIC) for primary treatment failure Acute Myeloid Leukemia (AML), to which future innovative strategies can be compared.

Phase:

Phase 2

Details

Lead Sponsor:

Nantes University Hospital

Treatments:

Clofarabine